ecSeq

Leipzig, Germany Founded: 2012 • Age: 14 yrs
Provider of computational tools for the analysis of genomic sequencing data

About ecSeq

ecSeq is a Healthcare company based in Leipzig (Germany) founded in 2012. ecSeq offers products and services including Custom NGS Software Development, Seamless NGS Services, and Public NGS Workshops. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis. Its legal entity is ecSeq Bioinformatics GmbH.

Company details

Provider of computational tools for the analysis of genomic sequencing data. EcSeq provides bioinformatics training covering the analyses of different high-throughput sequencing experiments. They also offer Knowledge-Driven NGS Solutions. They have established a wide network of scientists, covering all research fields relevant to NGS. Together with a project-specific expert panel, they can analyze NGS data in a scientifically proven manner to provide meaningful, knowledge-driven results. Their customers include large research organizations such as the Max-Planck Institute and the Helmholtz Centre, universities, hospitals, as well as large biotechnology and pharmaceutical companies.

Key Metrics

Products & Services of ecSeq

ecSeq offers a comprehensive portfolio of products and services, including Custom NGS Software Development, Seamless NGS Services, and Public NGS Workshops.

Custom NGS Software Development
Software Development

Tailored software for analyzing high-throughput sequencing data

Seamless NGS Services
Sequencing Services

Services for DNA-Seq, RNA-Seq, and epigenetics data analysis

Public NGS Workshops
Education

Training sessions on NGS data analysis techniques

Funding Insights of ecSeq

  • Total Rounds 2
  • Last Round Grant β€” $295,596
  • First Round $263,855

    (Jan 2017)

  • Investors Count 1

All 2 funding rounds of ecSeq with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2017$295,596Grant––
–
Jan 2017$263,855Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in ecSeq

ecSeq has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for ecSeq

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of ecSeq

3 dated milestones of ecSeq across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded ecSeq is founded.
  2. Funding First funding round of $264K.
  3. Funding Latest funding round, Grant, of $296K.

Web traffic of ecSeq

The website of ecSeq (ecseq.com) receives about 9.6K visits a month.

  • Monthly visits
    9.6K

    ▲ 2.5% vs previous month

Similar websites

Websites whose visitors overlap most with ecSeq. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
biostars.org
100%
#154,376View details
cibiv.at
cibiv.at
93%
#6,290,093–
wwtf.at
90%
11.6K#1,394,419View details
microbial-ecology.net
microbial-ecology.net
90%
–
rna-seqblog.com
88%
#669,184View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 12 similar websites and full traffic analytics for ecSeq

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 12 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ecSeq

ecSeq was founded in 2012 and raised its 1st funding round 5 years after it was founded.

ecSeq is headquartered in Leipzig, Germany. It is registered at Leipzig, Saxony, Germany.

Provider of computational tools for the analysis of genomic sequencing data. EcSeq provides bioinformatics training covering the analyses of different high-throughput sequencing experiments. They also offer Knowledge-Driven NGS Solutions. They have established a wide network of scientists, covering all research fields relevant to NGS. Together with a project-specific expert panel, they can analyze NGS data in a scientifically proven manner to provide meaningful, knowledge-driven results. Their customers include large research organizations such as the Max-Planck Institute and the Helmholtz Centre, universities, hospitals, as well as large biotechnology and pharmaceutical companies.

ecSeq offers Custom NGS Software Development, Seamless NGS Services, and Public NGS Workshops.

ecSeq has 1 investor. Key investors include European Union.

ecSeq operates through Ecseq Bioinformatics Gmbh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available